Dudediligence.

Serina Therapeutics, Inc

SERAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$14,000Sep ’24−$14,000Dec ’24$0.00Mar ’25$130,000Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Jun ’26
Net income, by quarter
$1.4MSep ’24−$2.7MDec ’24−$4.8MMar ’25−$6.4MJun ’25−$4.6MSep ’25−$3.3MDec ’25−$6.9MMar ’26−$6.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$144,000$34,000$3.2M$56,000$130,000
Gross profit$125,000$21,000$102,000none on filenone on file
Operating income−$7.9M−$7.0M−$3.1M−$17.0M−$24.0M
Net income−$8.7M−$10.5M$5.3M−$11.1M−$19.2M
Operating cash flow−$7.9M−$5.9M−$2.5M−$17.1M−$18.0M
Free cash flownone on filenone on file−$3.0M−$17.2M−$18.0M
Cash$584,000$645,000$7.6M$3.7M$3.1M
Debt$13.2M$18.1Mnone on filenone on filenone on file
Shares outstanding37.9M1.1M2.4M9.4M10.8M